K+ amino acid transporter KAAT1 mutant Y147F has increased transport activity and altered substrate selectivity
Zhilin Liu1,3,
Bruce R. Stevens2,
Daniel H. Feldman2,*,
Matthias A. Hediger3 and
William R. Harvey1,2,
1 The Whitney Laboratory, University of Florida, St Augustine, FL 32080,
USA
2 Department of Physiology and Functional Genomics, University of Florida
College of Medicine, Gainesville, FL 32610, USA
3 Harvard Institutes of Medicine, Harvard Medical School, Boston, MA 02115,
USA
* Present address: Research Department, Shriners Hospital for Children of
Northern California, Sacramento, CA 95817, USA.

View larger version (66K):
[in a new window]
|
Fig. 1. Predicted secondary structure of KAAT1 polypeptide, showing location of
mutations employed in the present study (blue, mutation; red, location) and
conserved tyrosine 147 (yellow Y in lower box) among related transporters.
|
|

View larger version (62K):
[in a new window]
|
Fig. 2. Targeting of expressed proteins to Xenopus oocyte plasma membrane
3 days after injection of anti-sense RNA from (A) wild-type (WT) (B) Y147F
mutant or (C) water control.
|
|

View larger version (12K):
[in a new window]
|
Fig. 3. Uptake of [3H]L-leucine by KAAT1 wild-type (WT) and several
mutants (Y147F, R76E and W75L). Accumulated radioactivity was measured in
oocytes after 30 min exposure to Na+ media containing 0.2 mmol
l-1 [3H]L-leucine. Oocytes had been injected 2-3 days
earlier with cRNA encoding W75L, R76E, Y147F, WT or water control.
|
|

View larger version (18K):
[in a new window]
|
Fig. 4. Typical amino acid selectivity spectrum for KAAT1 Y147F mutant and wild
type (WT; insert) in K+ and Na+ media. Data represent
net inward currents evoked by each amino acid in the presence of 100 mmol
l-1 cation.
|
|

View larger version (16K):
[in a new window]
|
Fig. 5. [3H]L-leucine uptake by KAAT1 (A) Y147F mutant and (B) wild type
(WT) in K+ media.
|
|

View larger version (12K):
[in a new window]
|
Fig. 6. Typical activation of L-leucine-associated net inward currents as a
function of leucine concentration in 100 mmoll-1
K+-containing medium. (A) KAAT1 Y147F mutant and (B) wild type
(WT).
|
|

View larger version (11K):
[in a new window]
|
Fig. 7. Typical activation of L-leucine-associated net inward current as a function
of K+ concentration in 500 µmoll-1 leucine-containing
medium. (A) KAAT1 Y147F mutant and (B) wild type (WT).
|
|

View larger version (14K):
[in a new window]
|
Fig. 8. Typical Li+-, K+- and Na+-induced currents
in mutant Y147F and wild type (WT).
|
|

View larger version (19K):
[in a new window]
|
Fig. 9. KAAT1 wild type (WT) uptake at pH 7.5 and pH 10. Upper panel: bars A and B,
0.2 mmoll-1 [3H]-L-leucine at pH 7.5 and pH 10,
respectively; C and D, 0.2 mmoll-1 [3H]-L-lysine uptake
at pH 7.5 and pH 10, respectively; E, 0.2 mmoll-1
[3H]-L-leucine uptake with 10 mmoll-1 lysine; F, 0.2
mmoll-1 [3H]-L-lysine with 10.0 mmoll-1
leucine; G and H, 10 mmoll-1 [3H]-L-leucine and 10
mmoll-1 [3H]-L-lysine uptake, respectively, by water-injected
oocytes. Lower panel: currents measured in KAAT1 cRNA-injected oocytes in
Na+-free K+ medium with lysine added (0.2
mmoll-1) and then removed.
|
|
© The Company of Biologists Ltd 2003